1,800
Participants
Start Date
March 9, 2022
Primary Completion Date
April 30, 2024
Study Completion Date
June 30, 2024
OraQuick HCV Antibody test (OraSure Technologies, Inc)
The OraQuick HCV test is a point of care antibody test for detecting HCV antibodies in fingerstick blood. The test takes 20 minutes to provide a result. Appropriate pre- and post-test counselling will be provided to participants.
Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid)
Xpert® HCV VL Fingerstick is an in vitro reverse transcription polymerase chain reaction (RT-PCR) assay for the detection and quantification of Hepatitis C Virus (HCV) RNA in human venous and capillary fingerstick EDTA whole blood. Only participants who return a reactive OraQuick HCV Antibody test will be offered the Xpert® HCV VL Fingerstick test. Appropriate pre- and post-test counselling will be provided to participants.
Sofosbuvir/Velpatasvir (Gilead)
Participants with a detectable HCV antibody will be offered treatment with sofosbuvir/velpatasvir.
RECRUITING
Innerspace, Collingwood
RECRUITING
Mediclinic Australia, Clayton South
RECRUITING
Corio Community Health Centre, Corio
RECRUITING
Homeless Healthcare, Highgate
RECRUITING
Cockburn Wellbeing, Success
RECRUITING
Cohealth Fitzroy, Fitzroy
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
OTHER